Breadcrumb Home / Investors & Media / node Explore Investors & Media Explore Investors & Media Investor Overview Press Releases Archived Press Releases Events & Presentations Corporate Governance Committee Composition Management Team Board of Directors Financials & Filings SEC Filings Stock Information Historical Stock Lookup Investment Calculator Analyst Coverage Investor FAQs Contact IR or Media Scholar Rock to Present Data from TOPAZ Ambulatory Cohort Analysis at the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference Read more about Scholar Rock to Present Data from TOPAZ Ambulatory Cohort Analysis at the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference Scholar Rock Reports Full Year 2021 Financial Results and Highlights Business Progress Read more about Scholar Rock Reports Full Year 2021 Financial Results and Highlights Business Progress Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference Read more about Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference Scholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit Read more about Scholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit Scholar Rock Provides Corporate Update and Highlights Priorities for 2022 Read more about Scholar Rock Provides Corporate Update and Highlights Priorities for 2022 Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference Read more about Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Read more about Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B Read more about Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress Read more about Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress Scholar Rock to Present at Upcoming Healthcare Conferences Read more about Scholar Rock to Present at Upcoming Healthcare Conferences Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last » Subscribe to RSS Feeds Search
Scholar Rock to Present Data from TOPAZ Ambulatory Cohort Analysis at the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference Read more about Scholar Rock to Present Data from TOPAZ Ambulatory Cohort Analysis at the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Scholar Rock Reports Full Year 2021 Financial Results and Highlights Business Progress Read more about Scholar Rock Reports Full Year 2021 Financial Results and Highlights Business Progress
Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference Read more about Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference
Scholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit Read more about Scholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit
Scholar Rock Provides Corporate Update and Highlights Priorities for 2022 Read more about Scholar Rock Provides Corporate Update and Highlights Priorities for 2022
Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference Read more about Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference
Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Read more about Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)
Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B Read more about Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B
Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress Read more about Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress
Scholar Rock to Present at Upcoming Healthcare Conferences Read more about Scholar Rock to Present at Upcoming Healthcare Conferences